Shuttle Pharmaceuticals Inc (SHPH) — Cash Flow-to-Debt Ratio
Shuttle Pharmaceuticals Inc (SHPH) has a Cash Flow-to-Debt Ratio of -0.12x as of December 2025, meaning its operating cash flow of $-973.01K could theoretically repay 0% of its total liabilities ($8.22 Million) in one year. See Shuttle Pharmaceuticals Inc (SHPH) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shuttle Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2017–2025)
Historical debt coverage capacity for Shuttle Pharmaceuticals Inc across 8 annual periods. Also explore SHPH net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Shuttle Pharmaceuticals Inc (2017–2025)
Year-by-year debt coverage analysis for Shuttle Pharmaceuticals Inc. For market capitalisation and broader financial context, see Shuttle Pharmaceuticals Inc (SHPH) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.15x | $-9.48 Million | $8.22 Million | ▲ +71.7% |
| 2024 | -4.08x | $-7.33 Million | $1.80 Million | ▼ -38.5% |
| 2023 | -2.94x | $-5.58 Million | $1.90 Million | ▼ -6.0% |
| 2022 | -2.78x | $-2.71 Million | $975.68K | ▼ -2008.7% |
| 2021 | -0.13x | $-300.34K | $2.28 Million | ▼ -997.1% |
| 2020 | -0.01x | $-26.83K | $2.23 Million | ▲ +98.7% |
| 2018 | -0.95x | $-566.69K | $593.82K | ▼ -91.0% |
| 2017 | -0.50x | $-202.71K | $405.65K | — |